Global Opioid Use Disorder Market Research Report 2024(Status and Outlook)
Report Overview:
An opioid is a synthetic or natural agent that stimulates opioid receptors and produces opium-like effects. Opioid use disorder is a problematic pattern of opioid use that causes significant impairment or distress.
The Global Opioid Use Disorder Market Size was estimated at USD 1255.82 million in 2023 and is projected to reach USD 1751.37 million by 2029, exhibiting a CAGR of 5.70% during the forecast period.
This report provides a deep insight into the global Opioid Use Disorder market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Opioid Use Disorder Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Opioid Use Disorder market in any manner.
Global Opioid Use Disorder Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Indivior
Alkermes
Titan Pharmaceuticals
Hikma Pharmaceuticals
Teva Pharmaceuticals
MediciNova
Orexo
Camurus
Omeros
Market Segmentation (by Type)
Buprenorphine
Methadone
Naltrexone
Market Segmentation (by Application)
Moderate Pain Treatment
Severe Pain Treatment
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Opioid Use Disorder Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
An opioid is a synthetic or natural agent that stimulates opioid receptors and produces opium-like effects. Opioid use disorder is a problematic pattern of opioid use that causes significant impairment or distress.
The Global Opioid Use Disorder Market Size was estimated at USD 1255.82 million in 2023 and is projected to reach USD 1751.37 million by 2029, exhibiting a CAGR of 5.70% during the forecast period.
This report provides a deep insight into the global Opioid Use Disorder market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Opioid Use Disorder Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Opioid Use Disorder market in any manner.
Global Opioid Use Disorder Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Indivior
Alkermes
Titan Pharmaceuticals
Hikma Pharmaceuticals
Teva Pharmaceuticals
MediciNova
Orexo
Camurus
Omeros
Market Segmentation (by Type)
Buprenorphine
Methadone
Naltrexone
Market Segmentation (by Application)
Moderate Pain Treatment
Severe Pain Treatment
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Opioid Use Disorder Market
- Overview of the regional outlook of the Opioid Use Disorder Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Opioid Use Disorder Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Opioid Use Disorder
1.2 Key Market Segments
1.2.1 Opioid Use Disorder Segment by Type
1.2.2 Opioid Use Disorder Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 OPIOID USE DISORDER MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Opioid Use Disorder Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Opioid Use Disorder Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 OPIOID USE DISORDER MARKET COMPETITIVE LANDSCAPE
3.1 Global Opioid Use Disorder Sales by Manufacturers (2019-2024)
3.2 Global Opioid Use Disorder Revenue Market Share by Manufacturers (2019-2024)
3.3 Opioid Use Disorder Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Opioid Use Disorder Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Opioid Use Disorder Sales Sites, Area Served, Product Type
3.6 Opioid Use Disorder Market Competitive Situation and Trends
3.6.1 Opioid Use Disorder Market Concentration Rate
3.6.2 Global 5 and 10 Largest Opioid Use Disorder Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 OPIOID USE DISORDER INDUSTRY CHAIN ANALYSIS
4.1 Opioid Use Disorder Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF OPIOID USE DISORDER MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 OPIOID USE DISORDER MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Opioid Use Disorder Sales Market Share by Type (2019-2024)
6.3 Global Opioid Use Disorder Market Size Market Share by Type (2019-2024)
6.4 Global Opioid Use Disorder Price by Type (2019-2024)
7 OPIOID USE DISORDER MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Opioid Use Disorder Market Sales by Application (2019-2024)
7.3 Global Opioid Use Disorder Market Size (M USD) by Application (2019-2024)
7.4 Global Opioid Use Disorder Sales Growth Rate by Application (2019-2024)
8 OPIOID USE DISORDER MARKET SEGMENTATION BY REGION
8.1 Global Opioid Use Disorder Sales by Region
8.1.1 Global Opioid Use Disorder Sales by Region
8.1.2 Global Opioid Use Disorder Sales Market Share by Region
8.2 North America
8.2.1 North America Opioid Use Disorder Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Opioid Use Disorder Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Opioid Use Disorder Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Opioid Use Disorder Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Opioid Use Disorder Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Indivior
9.1.1 Indivior Opioid Use Disorder Basic Information
9.1.2 Indivior Opioid Use Disorder Product Overview
9.1.3 Indivior Opioid Use Disorder Product Market Performance
9.1.4 Indivior Business Overview
9.1.5 Indivior Opioid Use Disorder SWOT Analysis
9.1.6 Indivior Recent Developments
9.2 Alkermes
9.2.1 Alkermes Opioid Use Disorder Basic Information
9.2.2 Alkermes Opioid Use Disorder Product Overview
9.2.3 Alkermes Opioid Use Disorder Product Market Performance
9.2.4 Alkermes Business Overview
9.2.5 Alkermes Opioid Use Disorder SWOT Analysis
9.2.6 Alkermes Recent Developments
9.3 Titan Pharmaceuticals
9.3.1 Titan Pharmaceuticals Opioid Use Disorder Basic Information
9.3.2 Titan Pharmaceuticals Opioid Use Disorder Product Overview
9.3.3 Titan Pharmaceuticals Opioid Use Disorder Product Market Performance
9.3.4 Titan Pharmaceuticals Opioid Use Disorder SWOT Analysis
9.3.5 Titan Pharmaceuticals Business Overview
9.3.6 Titan Pharmaceuticals Recent Developments
9.4 Hikma Pharmaceuticals
9.4.1 Hikma Pharmaceuticals Opioid Use Disorder Basic Information
9.4.2 Hikma Pharmaceuticals Opioid Use Disorder Product Overview
9.4.3 Hikma Pharmaceuticals Opioid Use Disorder Product Market Performance
9.4.4 Hikma Pharmaceuticals Business Overview
9.4.5 Hikma Pharmaceuticals Recent Developments
9.5 Teva Pharmaceuticals
9.5.1 Teva Pharmaceuticals Opioid Use Disorder Basic Information
9.5.2 Teva Pharmaceuticals Opioid Use Disorder Product Overview
9.5.3 Teva Pharmaceuticals Opioid Use Disorder Product Market Performance
9.5.4 Teva Pharmaceuticals Business Overview
9.5.5 Teva Pharmaceuticals Recent Developments
9.6 MediciNova
9.6.1 MediciNova Opioid Use Disorder Basic Information
9.6.2 MediciNova Opioid Use Disorder Product Overview
9.6.3 MediciNova Opioid Use Disorder Product Market Performance
9.6.4 MediciNova Business Overview
9.6.5 MediciNova Recent Developments
9.7 Orexo
9.7.1 Orexo Opioid Use Disorder Basic Information
9.7.2 Orexo Opioid Use Disorder Product Overview
9.7.3 Orexo Opioid Use Disorder Product Market Performance
9.7.4 Orexo Business Overview
9.7.5 Orexo Recent Developments
9.8 Camurus
9.8.1 Camurus Opioid Use Disorder Basic Information
9.8.2 Camurus Opioid Use Disorder Product Overview
9.8.3 Camurus Opioid Use Disorder Product Market Performance
9.8.4 Camurus Business Overview
9.8.5 Camurus Recent Developments
9.9 Omeros
9.9.1 Omeros Opioid Use Disorder Basic Information
9.9.2 Omeros Opioid Use Disorder Product Overview
9.9.3 Omeros Opioid Use Disorder Product Market Performance
9.9.4 Omeros Business Overview
9.9.5 Omeros Recent Developments
10 OPIOID USE DISORDER MARKET FORECAST BY REGION
10.1 Global Opioid Use Disorder Market Size Forecast
10.2 Global Opioid Use Disorder Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Opioid Use Disorder Market Size Forecast by Country
10.2.3 Asia Pacific Opioid Use Disorder Market Size Forecast by Region
10.2.4 South America Opioid Use Disorder Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Opioid Use Disorder by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Opioid Use Disorder Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Opioid Use Disorder by Type (2025-2030)
11.1.2 Global Opioid Use Disorder Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Opioid Use Disorder by Type (2025-2030)
11.2 Global Opioid Use Disorder Market Forecast by Application (2025-2030)
11.2.1 Global Opioid Use Disorder Sales (K Units) Forecast by Application
11.2.2 Global Opioid Use Disorder Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Opioid Use Disorder
1.2 Key Market Segments
1.2.1 Opioid Use Disorder Segment by Type
1.2.2 Opioid Use Disorder Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 OPIOID USE DISORDER MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Opioid Use Disorder Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Opioid Use Disorder Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 OPIOID USE DISORDER MARKET COMPETITIVE LANDSCAPE
3.1 Global Opioid Use Disorder Sales by Manufacturers (2019-2024)
3.2 Global Opioid Use Disorder Revenue Market Share by Manufacturers (2019-2024)
3.3 Opioid Use Disorder Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Opioid Use Disorder Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Opioid Use Disorder Sales Sites, Area Served, Product Type
3.6 Opioid Use Disorder Market Competitive Situation and Trends
3.6.1 Opioid Use Disorder Market Concentration Rate
3.6.2 Global 5 and 10 Largest Opioid Use Disorder Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 OPIOID USE DISORDER INDUSTRY CHAIN ANALYSIS
4.1 Opioid Use Disorder Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF OPIOID USE DISORDER MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 OPIOID USE DISORDER MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Opioid Use Disorder Sales Market Share by Type (2019-2024)
6.3 Global Opioid Use Disorder Market Size Market Share by Type (2019-2024)
6.4 Global Opioid Use Disorder Price by Type (2019-2024)
7 OPIOID USE DISORDER MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Opioid Use Disorder Market Sales by Application (2019-2024)
7.3 Global Opioid Use Disorder Market Size (M USD) by Application (2019-2024)
7.4 Global Opioid Use Disorder Sales Growth Rate by Application (2019-2024)
8 OPIOID USE DISORDER MARKET SEGMENTATION BY REGION
8.1 Global Opioid Use Disorder Sales by Region
8.1.1 Global Opioid Use Disorder Sales by Region
8.1.2 Global Opioid Use Disorder Sales Market Share by Region
8.2 North America
8.2.1 North America Opioid Use Disorder Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Opioid Use Disorder Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Opioid Use Disorder Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Opioid Use Disorder Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Opioid Use Disorder Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Indivior
9.1.1 Indivior Opioid Use Disorder Basic Information
9.1.2 Indivior Opioid Use Disorder Product Overview
9.1.3 Indivior Opioid Use Disorder Product Market Performance
9.1.4 Indivior Business Overview
9.1.5 Indivior Opioid Use Disorder SWOT Analysis
9.1.6 Indivior Recent Developments
9.2 Alkermes
9.2.1 Alkermes Opioid Use Disorder Basic Information
9.2.2 Alkermes Opioid Use Disorder Product Overview
9.2.3 Alkermes Opioid Use Disorder Product Market Performance
9.2.4 Alkermes Business Overview
9.2.5 Alkermes Opioid Use Disorder SWOT Analysis
9.2.6 Alkermes Recent Developments
9.3 Titan Pharmaceuticals
9.3.1 Titan Pharmaceuticals Opioid Use Disorder Basic Information
9.3.2 Titan Pharmaceuticals Opioid Use Disorder Product Overview
9.3.3 Titan Pharmaceuticals Opioid Use Disorder Product Market Performance
9.3.4 Titan Pharmaceuticals Opioid Use Disorder SWOT Analysis
9.3.5 Titan Pharmaceuticals Business Overview
9.3.6 Titan Pharmaceuticals Recent Developments
9.4 Hikma Pharmaceuticals
9.4.1 Hikma Pharmaceuticals Opioid Use Disorder Basic Information
9.4.2 Hikma Pharmaceuticals Opioid Use Disorder Product Overview
9.4.3 Hikma Pharmaceuticals Opioid Use Disorder Product Market Performance
9.4.4 Hikma Pharmaceuticals Business Overview
9.4.5 Hikma Pharmaceuticals Recent Developments
9.5 Teva Pharmaceuticals
9.5.1 Teva Pharmaceuticals Opioid Use Disorder Basic Information
9.5.2 Teva Pharmaceuticals Opioid Use Disorder Product Overview
9.5.3 Teva Pharmaceuticals Opioid Use Disorder Product Market Performance
9.5.4 Teva Pharmaceuticals Business Overview
9.5.5 Teva Pharmaceuticals Recent Developments
9.6 MediciNova
9.6.1 MediciNova Opioid Use Disorder Basic Information
9.6.2 MediciNova Opioid Use Disorder Product Overview
9.6.3 MediciNova Opioid Use Disorder Product Market Performance
9.6.4 MediciNova Business Overview
9.6.5 MediciNova Recent Developments
9.7 Orexo
9.7.1 Orexo Opioid Use Disorder Basic Information
9.7.2 Orexo Opioid Use Disorder Product Overview
9.7.3 Orexo Opioid Use Disorder Product Market Performance
9.7.4 Orexo Business Overview
9.7.5 Orexo Recent Developments
9.8 Camurus
9.8.1 Camurus Opioid Use Disorder Basic Information
9.8.2 Camurus Opioid Use Disorder Product Overview
9.8.3 Camurus Opioid Use Disorder Product Market Performance
9.8.4 Camurus Business Overview
9.8.5 Camurus Recent Developments
9.9 Omeros
9.9.1 Omeros Opioid Use Disorder Basic Information
9.9.2 Omeros Opioid Use Disorder Product Overview
9.9.3 Omeros Opioid Use Disorder Product Market Performance
9.9.4 Omeros Business Overview
9.9.5 Omeros Recent Developments
10 OPIOID USE DISORDER MARKET FORECAST BY REGION
10.1 Global Opioid Use Disorder Market Size Forecast
10.2 Global Opioid Use Disorder Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Opioid Use Disorder Market Size Forecast by Country
10.2.3 Asia Pacific Opioid Use Disorder Market Size Forecast by Region
10.2.4 South America Opioid Use Disorder Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Opioid Use Disorder by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Opioid Use Disorder Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Opioid Use Disorder by Type (2025-2030)
11.1.2 Global Opioid Use Disorder Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Opioid Use Disorder by Type (2025-2030)
11.2 Global Opioid Use Disorder Market Forecast by Application (2025-2030)
11.2.1 Global Opioid Use Disorder Sales (K Units) Forecast by Application
11.2.2 Global Opioid Use Disorder Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Opioid Use Disorder Market Size Comparison by Region (M USD)
Table 5. Global Opioid Use Disorder Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Opioid Use Disorder Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Opioid Use Disorder Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Opioid Use Disorder Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Use Disorder as of 2022)
Table 10. Global Market Opioid Use Disorder Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Opioid Use Disorder Sales Sites and Area Served
Table 12. Manufacturers Opioid Use Disorder Product Type
Table 13. Global Opioid Use Disorder Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Opioid Use Disorder
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Opioid Use Disorder Market Challenges
Table 22. Global Opioid Use Disorder Sales by Type (K Units)
Table 23. Global Opioid Use Disorder Market Size by Type (M USD)
Table 24. Global Opioid Use Disorder Sales (K Units) by Type (2019-2024)
Table 25. Global Opioid Use Disorder Sales Market Share by Type (2019-2024)
Table 26. Global Opioid Use Disorder Market Size (M USD) by Type (2019-2024)
Table 27. Global Opioid Use Disorder Market Size Share by Type (2019-2024)
Table 28. Global Opioid Use Disorder Price (USD/Unit) by Type (2019-2024)
Table 29. Global Opioid Use Disorder Sales (K Units) by Application
Table 30. Global Opioid Use Disorder Market Size by Application
Table 31. Global Opioid Use Disorder Sales by Application (2019-2024) & (K Units)
Table 32. Global Opioid Use Disorder Sales Market Share by Application (2019-2024)
Table 33. Global Opioid Use Disorder Sales by Application (2019-2024) & (M USD)
Table 34. Global Opioid Use Disorder Market Share by Application (2019-2024)
Table 35. Global Opioid Use Disorder Sales Growth Rate by Application (2019-2024)
Table 36. Global Opioid Use Disorder Sales by Region (2019-2024) & (K Units)
Table 37. Global Opioid Use Disorder Sales Market Share by Region (2019-2024)
Table 38. North America Opioid Use Disorder Sales by Country (2019-2024) & (K Units)
Table 39. Europe Opioid Use Disorder Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Opioid Use Disorder Sales by Region (2019-2024) & (K Units)
Table 41. South America Opioid Use Disorder Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Opioid Use Disorder Sales by Region (2019-2024) & (K Units)
Table 43. Indivior Opioid Use Disorder Basic Information
Table 44. Indivior Opioid Use Disorder Product Overview
Table 45. Indivior Opioid Use Disorder Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Indivior Business Overview
Table 47. Indivior Opioid Use Disorder SWOT Analysis
Table 48. Indivior Recent Developments
Table 49. Alkermes Opioid Use Disorder Basic Information
Table 50. Alkermes Opioid Use Disorder Product Overview
Table 51. Alkermes Opioid Use Disorder Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Alkermes Business Overview
Table 53. Alkermes Opioid Use Disorder SWOT Analysis
Table 54. Alkermes Recent Developments
Table 55. Titan Pharmaceuticals Opioid Use Disorder Basic Information
Table 56. Titan Pharmaceuticals Opioid Use Disorder Product Overview
Table 57. Titan Pharmaceuticals Opioid Use Disorder Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Titan Pharmaceuticals Opioid Use Disorder SWOT Analysis
Table 59. Titan Pharmaceuticals Business Overview
Table 60. Titan Pharmaceuticals Recent Developments
Table 61. Hikma Pharmaceuticals Opioid Use Disorder Basic Information
Table 62. Hikma Pharmaceuticals Opioid Use Disorder Product Overview
Table 63. Hikma Pharmaceuticals Opioid Use Disorder Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Hikma Pharmaceuticals Business Overview
Table 65. Hikma Pharmaceuticals Recent Developments
Table 66. Teva Pharmaceuticals Opioid Use Disorder Basic Information
Table 67. Teva Pharmaceuticals Opioid Use Disorder Product Overview
Table 68. Teva Pharmaceuticals Opioid Use Disorder Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Teva Pharmaceuticals Business Overview
Table 70. Teva Pharmaceuticals Recent Developments
Table 71. MediciNova Opioid Use Disorder Basic Information
Table 72. MediciNova Opioid Use Disorder Product Overview
Table 73. MediciNova Opioid Use Disorder Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. MediciNova Business Overview
Table 75. MediciNova Recent Developments
Table 76. Orexo Opioid Use Disorder Basic Information
Table 77. Orexo Opioid Use Disorder Product Overview
Table 78. Orexo Opioid Use Disorder Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Orexo Business Overview
Table 80. Orexo Recent Developments
Table 81. Camurus Opioid Use Disorder Basic Information
Table 82. Camurus Opioid Use Disorder Product Overview
Table 83. Camurus Opioid Use Disorder Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Camurus Business Overview
Table 85. Camurus Recent Developments
Table 86. Omeros Opioid Use Disorder Basic Information
Table 87. Omeros Opioid Use Disorder Product Overview
Table 88. Omeros Opioid Use Disorder Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Omeros Business Overview
Table 90. Omeros Recent Developments
Table 91. Global Opioid Use Disorder Sales Forecast by Region (2025-2030) & (K Units)
Table 92. Global Opioid Use Disorder Market Size Forecast by Region (2025-2030) & (M USD)
Table 93. North America Opioid Use Disorder Sales Forecast by Country (2025-2030) & (K Units)
Table 94. North America Opioid Use Disorder Market Size Forecast by Country (2025-2030) & (M USD)
Table 95. Europe Opioid Use Disorder Sales Forecast by Country (2025-2030) & (K Units)
Table 96. Europe Opioid Use Disorder Market Size Forecast by Country (2025-2030) & (M USD)
Table 97. Asia Pacific Opioid Use Disorder Sales Forecast by Region (2025-2030) & (K Units)
Table 98. Asia Pacific Opioid Use Disorder Market Size Forecast by Region (2025-2030) & (M USD)
Table 99. South America Opioid Use Disorder Sales Forecast by Country (2025-2030) & (K Units)
Table 100. South America Opioid Use Disorder Market Size Forecast by Country (2025-2030) & (M USD)
Table 101. Middle East and Africa Opioid Use Disorder Consumption Forecast by Country (2025-2030) & (Units)
Table 102. Middle East and Africa Opioid Use Disorder Market Size Forecast by Country (2025-2030) & (M USD)
Table 103. Global Opioid Use Disorder Sales Forecast by Type (2025-2030) & (K Units)
Table 104. Global Opioid Use Disorder Market Size Forecast by Type (2025-2030) & (M USD)
Table 105. Global Opioid Use Disorder Price Forecast by Type (2025-2030) & (USD/Unit)
Table 106. Global Opioid Use Disorder Sales (K Units) Forecast by Application (2025-2030)
Table 107. Global Opioid Use Disorder Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Opioid Use Disorder Market Size Comparison by Region (M USD)
Table 5. Global Opioid Use Disorder Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Opioid Use Disorder Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Opioid Use Disorder Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Opioid Use Disorder Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Use Disorder as of 2022)
Table 10. Global Market Opioid Use Disorder Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Opioid Use Disorder Sales Sites and Area Served
Table 12. Manufacturers Opioid Use Disorder Product Type
Table 13. Global Opioid Use Disorder Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Opioid Use Disorder
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Opioid Use Disorder Market Challenges
Table 22. Global Opioid Use Disorder Sales by Type (K Units)
Table 23. Global Opioid Use Disorder Market Size by Type (M USD)
Table 24. Global Opioid Use Disorder Sales (K Units) by Type (2019-2024)
Table 25. Global Opioid Use Disorder Sales Market Share by Type (2019-2024)
Table 26. Global Opioid Use Disorder Market Size (M USD) by Type (2019-2024)
Table 27. Global Opioid Use Disorder Market Size Share by Type (2019-2024)
Table 28. Global Opioid Use Disorder Price (USD/Unit) by Type (2019-2024)
Table 29. Global Opioid Use Disorder Sales (K Units) by Application
Table 30. Global Opioid Use Disorder Market Size by Application
Table 31. Global Opioid Use Disorder Sales by Application (2019-2024) & (K Units)
Table 32. Global Opioid Use Disorder Sales Market Share by Application (2019-2024)
Table 33. Global Opioid Use Disorder Sales by Application (2019-2024) & (M USD)
Table 34. Global Opioid Use Disorder Market Share by Application (2019-2024)
Table 35. Global Opioid Use Disorder Sales Growth Rate by Application (2019-2024)
Table 36. Global Opioid Use Disorder Sales by Region (2019-2024) & (K Units)
Table 37. Global Opioid Use Disorder Sales Market Share by Region (2019-2024)
Table 38. North America Opioid Use Disorder Sales by Country (2019-2024) & (K Units)
Table 39. Europe Opioid Use Disorder Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Opioid Use Disorder Sales by Region (2019-2024) & (K Units)
Table 41. South America Opioid Use Disorder Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Opioid Use Disorder Sales by Region (2019-2024) & (K Units)
Table 43. Indivior Opioid Use Disorder Basic Information
Table 44. Indivior Opioid Use Disorder Product Overview
Table 45. Indivior Opioid Use Disorder Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Indivior Business Overview
Table 47. Indivior Opioid Use Disorder SWOT Analysis
Table 48. Indivior Recent Developments
Table 49. Alkermes Opioid Use Disorder Basic Information
Table 50. Alkermes Opioid Use Disorder Product Overview
Table 51. Alkermes Opioid Use Disorder Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Alkermes Business Overview
Table 53. Alkermes Opioid Use Disorder SWOT Analysis
Table 54. Alkermes Recent Developments
Table 55. Titan Pharmaceuticals Opioid Use Disorder Basic Information
Table 56. Titan Pharmaceuticals Opioid Use Disorder Product Overview
Table 57. Titan Pharmaceuticals Opioid Use Disorder Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Titan Pharmaceuticals Opioid Use Disorder SWOT Analysis
Table 59. Titan Pharmaceuticals Business Overview
Table 60. Titan Pharmaceuticals Recent Developments
Table 61. Hikma Pharmaceuticals Opioid Use Disorder Basic Information
Table 62. Hikma Pharmaceuticals Opioid Use Disorder Product Overview
Table 63. Hikma Pharmaceuticals Opioid Use Disorder Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Hikma Pharmaceuticals Business Overview
Table 65. Hikma Pharmaceuticals Recent Developments
Table 66. Teva Pharmaceuticals Opioid Use Disorder Basic Information
Table 67. Teva Pharmaceuticals Opioid Use Disorder Product Overview
Table 68. Teva Pharmaceuticals Opioid Use Disorder Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Teva Pharmaceuticals Business Overview
Table 70. Teva Pharmaceuticals Recent Developments
Table 71. MediciNova Opioid Use Disorder Basic Information
Table 72. MediciNova Opioid Use Disorder Product Overview
Table 73. MediciNova Opioid Use Disorder Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. MediciNova Business Overview
Table 75. MediciNova Recent Developments
Table 76. Orexo Opioid Use Disorder Basic Information
Table 77. Orexo Opioid Use Disorder Product Overview
Table 78. Orexo Opioid Use Disorder Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Orexo Business Overview
Table 80. Orexo Recent Developments
Table 81. Camurus Opioid Use Disorder Basic Information
Table 82. Camurus Opioid Use Disorder Product Overview
Table 83. Camurus Opioid Use Disorder Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Camurus Business Overview
Table 85. Camurus Recent Developments
Table 86. Omeros Opioid Use Disorder Basic Information
Table 87. Omeros Opioid Use Disorder Product Overview
Table 88. Omeros Opioid Use Disorder Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Omeros Business Overview
Table 90. Omeros Recent Developments
Table 91. Global Opioid Use Disorder Sales Forecast by Region (2025-2030) & (K Units)
Table 92. Global Opioid Use Disorder Market Size Forecast by Region (2025-2030) & (M USD)
Table 93. North America Opioid Use Disorder Sales Forecast by Country (2025-2030) & (K Units)
Table 94. North America Opioid Use Disorder Market Size Forecast by Country (2025-2030) & (M USD)
Table 95. Europe Opioid Use Disorder Sales Forecast by Country (2025-2030) & (K Units)
Table 96. Europe Opioid Use Disorder Market Size Forecast by Country (2025-2030) & (M USD)
Table 97. Asia Pacific Opioid Use Disorder Sales Forecast by Region (2025-2030) & (K Units)
Table 98. Asia Pacific Opioid Use Disorder Market Size Forecast by Region (2025-2030) & (M USD)
Table 99. South America Opioid Use Disorder Sales Forecast by Country (2025-2030) & (K Units)
Table 100. South America Opioid Use Disorder Market Size Forecast by Country (2025-2030) & (M USD)
Table 101. Middle East and Africa Opioid Use Disorder Consumption Forecast by Country (2025-2030) & (Units)
Table 102. Middle East and Africa Opioid Use Disorder Market Size Forecast by Country (2025-2030) & (M USD)
Table 103. Global Opioid Use Disorder Sales Forecast by Type (2025-2030) & (K Units)
Table 104. Global Opioid Use Disorder Market Size Forecast by Type (2025-2030) & (M USD)
Table 105. Global Opioid Use Disorder Price Forecast by Type (2025-2030) & (USD/Unit)
Table 106. Global Opioid Use Disorder Sales (K Units) Forecast by Application (2025-2030)
Table 107. Global Opioid Use Disorder Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Opioid Use Disorder
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Opioid Use Disorder Market Size (M USD), 2019-2030
Figure 5. Global Opioid Use Disorder Market Size (M USD) (2019-2030)
Figure 6. Global Opioid Use Disorder Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Opioid Use Disorder Market Size by Country (M USD)
Figure 11. Opioid Use Disorder Sales Share by Manufacturers in 2023
Figure 12. Global Opioid Use Disorder Revenue Share by Manufacturers in 2023
Figure 13. Opioid Use Disorder Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Opioid Use Disorder Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Opioid Use Disorder Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Opioid Use Disorder Market Share by Type
Figure 18. Sales Market Share of Opioid Use Disorder by Type (2019-2024)
Figure 19. Sales Market Share of Opioid Use Disorder by Type in 2023
Figure 20. Market Size Share of Opioid Use Disorder by Type (2019-2024)
Figure 21. Market Size Market Share of Opioid Use Disorder by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Opioid Use Disorder Market Share by Application
Figure 24. Global Opioid Use Disorder Sales Market Share by Application (2019-2024)
Figure 25. Global Opioid Use Disorder Sales Market Share by Application in 2023
Figure 26. Global Opioid Use Disorder Market Share by Application (2019-2024)
Figure 27. Global Opioid Use Disorder Market Share by Application in 2023
Figure 28. Global Opioid Use Disorder Sales Growth Rate by Application (2019-2024)
Figure 29. Global Opioid Use Disorder Sales Market Share by Region (2019-2024)
Figure 30. North America Opioid Use Disorder Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Opioid Use Disorder Sales Market Share by Country in 2023
Figure 32. U.S. Opioid Use Disorder Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Opioid Use Disorder Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Opioid Use Disorder Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Opioid Use Disorder Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Opioid Use Disorder Sales Market Share by Country in 2023
Figure 37. Germany Opioid Use Disorder Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Opioid Use Disorder Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Opioid Use Disorder Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Opioid Use Disorder Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Opioid Use Disorder Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Opioid Use Disorder Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Opioid Use Disorder Sales Market Share by Region in 2023
Figure 44. China Opioid Use Disorder Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Opioid Use Disorder Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Opioid Use Disorder Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Opioid Use Disorder Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Opioid Use Disorder Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Opioid Use Disorder Sales and Growth Rate (K Units)
Figure 50. South America Opioid Use Disorder Sales Market Share by Country in 2023
Figure 51. Brazil Opioid Use Disorder Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Opioid Use Disorder Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Opioid Use Disorder Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Opioid Use Disorder Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Opioid Use Disorder Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Opioid Use Disorder Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Opioid Use Disorder Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Opioid Use Disorder Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Opioid Use Disorder Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Opioid Use Disorder Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Opioid Use Disorder Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Opioid Use Disorder Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Opioid Use Disorder Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Opioid Use Disorder Market Share Forecast by Type (2025-2030)
Figure 65. Global Opioid Use Disorder Sales Forecast by Application (2025-2030)
Figure 66. Global Opioid Use Disorder Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Opioid Use Disorder
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Opioid Use Disorder Market Size (M USD), 2019-2030
Figure 5. Global Opioid Use Disorder Market Size (M USD) (2019-2030)
Figure 6. Global Opioid Use Disorder Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Opioid Use Disorder Market Size by Country (M USD)
Figure 11. Opioid Use Disorder Sales Share by Manufacturers in 2023
Figure 12. Global Opioid Use Disorder Revenue Share by Manufacturers in 2023
Figure 13. Opioid Use Disorder Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Opioid Use Disorder Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Opioid Use Disorder Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Opioid Use Disorder Market Share by Type
Figure 18. Sales Market Share of Opioid Use Disorder by Type (2019-2024)
Figure 19. Sales Market Share of Opioid Use Disorder by Type in 2023
Figure 20. Market Size Share of Opioid Use Disorder by Type (2019-2024)
Figure 21. Market Size Market Share of Opioid Use Disorder by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Opioid Use Disorder Market Share by Application
Figure 24. Global Opioid Use Disorder Sales Market Share by Application (2019-2024)
Figure 25. Global Opioid Use Disorder Sales Market Share by Application in 2023
Figure 26. Global Opioid Use Disorder Market Share by Application (2019-2024)
Figure 27. Global Opioid Use Disorder Market Share by Application in 2023
Figure 28. Global Opioid Use Disorder Sales Growth Rate by Application (2019-2024)
Figure 29. Global Opioid Use Disorder Sales Market Share by Region (2019-2024)
Figure 30. North America Opioid Use Disorder Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Opioid Use Disorder Sales Market Share by Country in 2023
Figure 32. U.S. Opioid Use Disorder Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Opioid Use Disorder Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Opioid Use Disorder Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Opioid Use Disorder Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Opioid Use Disorder Sales Market Share by Country in 2023
Figure 37. Germany Opioid Use Disorder Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Opioid Use Disorder Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Opioid Use Disorder Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Opioid Use Disorder Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Opioid Use Disorder Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Opioid Use Disorder Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Opioid Use Disorder Sales Market Share by Region in 2023
Figure 44. China Opioid Use Disorder Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Opioid Use Disorder Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Opioid Use Disorder Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Opioid Use Disorder Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Opioid Use Disorder Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Opioid Use Disorder Sales and Growth Rate (K Units)
Figure 50. South America Opioid Use Disorder Sales Market Share by Country in 2023
Figure 51. Brazil Opioid Use Disorder Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Opioid Use Disorder Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Opioid Use Disorder Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Opioid Use Disorder Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Opioid Use Disorder Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Opioid Use Disorder Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Opioid Use Disorder Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Opioid Use Disorder Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Opioid Use Disorder Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Opioid Use Disorder Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Opioid Use Disorder Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Opioid Use Disorder Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Opioid Use Disorder Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Opioid Use Disorder Market Share Forecast by Type (2025-2030)
Figure 65. Global Opioid Use Disorder Sales Forecast by Application (2025-2030)
Figure 66. Global Opioid Use Disorder Market Share Forecast by Application (2025-2030)
